lost patients / patience

In Nov 2010 it was announced that dosing of the first of its 150 paediatric patients has commenced in Rawanda.This was the first of 4 sites. Now in July the announcement was made that 50 had been treated in Rwanda and a further 50 were being recruited in Burkina Faso.

As the Phase III tests is all about trialling and proof of product I am at a loss to understand the apparant lack of urgency shown by our testing partners. The loss of Mr Calvin Ross has had a greater impact than was ever envisaged.Surely they can provide EMS Management with a time line against which EMS can measure progress.

OR

Is it time to think about finding a new testing partner or are we to closely joined at the hip???

I will be staggered if the Q3 expectation is met.